vs
Side-by-side financial comparison of Acadia Healthcare Company, Inc. (ACHC) and Noble Corp plc (NE). Click either name above to swap in a different company.
Acadia Healthcare Company, Inc. is the larger business by last-quarter revenue ($829.0M vs $764.4M, roughly 1.1× Noble Corp plc). Noble Corp plc runs the higher net margin — 11.3% vs 0.5%, a 10.8% gap on every dollar of revenue. On growth, Acadia Healthcare Company, Inc. posted the faster year-over-year revenue change (7.5% vs -17.6%). Over the past eight quarters, Noble Corp plc's revenue compounded faster (9.5% CAGR vs 2.0%).
Acadia Healthcare Company, Inc. is an American provider of for-profit behavioral healthcare services. It operates a network of over 225 facilities across the United States and Puerto Rico.
Barnes & Noble Booksellers is an American bookseller with the largest number of retail outlets in the United States. The company operates approximately 700+ retail stores across the United States.
ACHC vs NE — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $829.0M | $764.4M |
| Net Profit | $4.5M | $86.6M |
| Gross Margin | — | — |
| Operating Margin | — | 5.6% |
| Net Margin | 0.5% | 11.3% |
| Revenue YoY | 7.5% | -17.6% |
| Net Profit YoY | -50.8% | -10.4% |
| EPS (diluted) | $0.05 | $0.54 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $829.0M | — | ||
| Q4 25 | $821.5M | $764.4M | ||
| Q3 25 | $851.6M | $798.0M | ||
| Q2 25 | $869.2M | $848.7M | ||
| Q1 25 | $770.5M | $874.5M | ||
| Q4 24 | $774.2M | $927.3M | ||
| Q3 24 | $815.6M | $800.5M | ||
| Q2 24 | $796.0M | $692.8M |
| Q1 26 | $4.5M | — | ||
| Q4 25 | $-1.2B | $86.6M | ||
| Q3 25 | $36.2M | $-21.1M | ||
| Q2 25 | $30.1M | $42.9M | ||
| Q1 25 | $8.4M | $108.3M | ||
| Q4 24 | $32.6M | $96.6M | ||
| Q3 24 | $68.1M | $61.2M | ||
| Q2 24 | $78.5M | $195.0M |
| Q1 26 | — | — | ||
| Q4 25 | -142.4% | 5.6% | ||
| Q3 25 | 4.7% | 6.3% | ||
| Q2 25 | 5.8% | 15.9% | ||
| Q1 25 | 1.7% | 21.4% | ||
| Q4 24 | 4.9% | 18.4% | ||
| Q3 24 | 12.1% | 14.4% | ||
| Q2 24 | 13.4% | 30.3% |
| Q1 26 | 0.5% | — | ||
| Q4 25 | -143.3% | 11.3% | ||
| Q3 25 | 4.3% | -2.6% | ||
| Q2 25 | 3.5% | 5.1% | ||
| Q1 25 | 1.1% | 12.4% | ||
| Q4 24 | 4.2% | 10.4% | ||
| Q3 24 | 8.4% | 7.6% | ||
| Q2 24 | 9.9% | 28.1% |
| Q1 26 | $0.05 | — | ||
| Q4 25 | $-12.98 | $0.54 | ||
| Q3 25 | $0.40 | $-0.13 | ||
| Q2 25 | $0.33 | $0.27 | ||
| Q1 25 | $0.09 | $0.67 | ||
| Q4 24 | $0.36 | $0.56 | ||
| Q3 24 | $0.74 | $0.40 | ||
| Q2 24 | $0.85 | $1.34 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $158.5M | $471.4M |
| Total DebtLower is stronger | $2.5B | — |
| Stockholders' EquityBook value | $2.0B | $4.5B |
| Total Assets | $5.5B | $7.5B |
| Debt / EquityLower = less leverage | 1.29× | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $158.5M | — | ||
| Q4 25 | $133.2M | $471.4M | ||
| Q3 25 | $118.7M | $477.9M | ||
| Q2 25 | $131.4M | $338.2M | ||
| Q1 25 | $91.2M | $303.8M | ||
| Q4 24 | $76.3M | $247.3M | ||
| Q3 24 | $82.1M | $391.9M | ||
| Q2 24 | $77.2M | $162.9M |
| Q1 26 | $2.5B | — | ||
| Q4 25 | $2.5B | — | ||
| Q3 25 | $2.3B | — | ||
| Q2 25 | $2.3B | — | ||
| Q1 25 | $2.2B | — | ||
| Q4 24 | $2.0B | — | ||
| Q3 24 | $1.9B | — | ||
| Q2 24 | $1.8B | — |
| Q1 26 | $2.0B | — | ||
| Q4 25 | $1.9B | $4.5B | ||
| Q3 25 | $3.1B | $4.5B | ||
| Q2 25 | $3.1B | $4.6B | ||
| Q1 25 | $3.0B | $4.7B | ||
| Q4 24 | $3.1B | $4.7B | ||
| Q3 24 | $3.0B | $4.7B | ||
| Q2 24 | $3.0B | $4.0B |
| Q1 26 | $5.5B | — | ||
| Q4 25 | $5.5B | $7.5B | ||
| Q3 25 | $6.4B | $7.6B | ||
| Q2 25 | $6.3B | $7.7B | ||
| Q1 25 | $6.1B | $7.9B | ||
| Q4 24 | $6.0B | $8.0B | ||
| Q3 24 | $5.9B | $8.0B | ||
| Q2 24 | $5.7B | $5.6B |
| Q1 26 | 1.29× | — | ||
| Q4 25 | 1.28× | — | ||
| Q3 25 | 0.74× | — | ||
| Q2 25 | 0.74× | — | ||
| Q1 25 | 0.72× | — | ||
| Q4 24 | 0.64× | — | ||
| Q3 24 | 0.62× | — | ||
| Q2 24 | 0.62× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $61.5M | $187.1M |
| Free Cash FlowOCF − Capex | — | $35.4M |
| FCF MarginFCF / Revenue | — | 4.6% |
| Capex IntensityCapex / Revenue | — | 19.9% |
| Cash ConversionOCF / Net Profit | 13.78× | 2.16× |
| TTM Free Cash FlowTrailing 4 quarters | — | $432.2M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $61.5M | — | ||
| Q4 25 | $-86.3M | $187.1M | ||
| Q3 25 | $73.2M | $277.1M | ||
| Q2 25 | $133.5M | $216.4M | ||
| Q1 25 | $11.5M | $271.1M | ||
| Q4 24 | $116.7M | $136.2M | ||
| Q3 24 | $163.1M | $283.8M | ||
| Q2 24 | $171.1M | $106.8M |
| Q1 26 | — | — | ||
| Q4 25 | $-179.5M | $35.4M | ||
| Q3 25 | $-63.0M | $139.5M | ||
| Q2 25 | $-34.2M | $99.8M | ||
| Q1 25 | $-163.2M | $157.5M | ||
| Q4 24 | $-86.8M | $-4.4M | ||
| Q3 24 | $-27.1M | $156.8M | ||
| Q2 24 | $16.9M | $-34.3M |
| Q1 26 | — | — | ||
| Q4 25 | -21.8% | 4.6% | ||
| Q3 25 | -7.4% | 17.5% | ||
| Q2 25 | -3.9% | 11.8% | ||
| Q1 25 | -21.2% | 18.0% | ||
| Q4 24 | -11.2% | -0.5% | ||
| Q3 24 | -3.3% | 19.6% | ||
| Q2 24 | 2.1% | -4.9% |
| Q1 26 | — | — | ||
| Q4 25 | 11.3% | 19.9% | ||
| Q3 25 | 16.0% | 17.3% | ||
| Q2 25 | 19.3% | 13.7% | ||
| Q1 25 | 22.7% | 13.0% | ||
| Q4 24 | 26.3% | 15.2% | ||
| Q3 24 | 23.3% | 15.9% | ||
| Q2 24 | 19.4% | 20.4% |
| Q1 26 | 13.78× | — | ||
| Q4 25 | — | 2.16× | ||
| Q3 25 | 2.02× | — | ||
| Q2 25 | 4.43× | 5.05× | ||
| Q1 25 | 1.37× | 2.50× | ||
| Q4 24 | 3.58× | 1.41× | ||
| Q3 24 | 2.39× | 4.64× | ||
| Q2 24 | 2.18× | 0.55× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ACHC
| Acute Inpatient Psychiatric Facilities | $471.0M | 57% |
| Other | $140.0M | 17% |
| Specialty Treatment Facilities | $128.0M | 15% |
| Residential Treatment Facilities | $90.0M | 11% |
NE
| Floaters | $559.8M | 73% |
| Jackups | $145.5M | 19% |
| Service Other | $59.1M | 8% |
